AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

September 01, 2024
not-yet-known not-yet-known not-yet-known...
Gilda Varricchi, Remo Poto, Lommatzsch M., et al.
October 13, 2022
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma...
David Price, paul pfeffer, Nasloon Ali, et al.
May 26, 2021
What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on...
Enrico Maggi, Bruno Azzarone, Walter Canonica, et al.
February 18, 2021
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis w...
Ioana Agache, Yang Song, Pablo Alonso-Coello, et al.
December 28, 2020
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-AR...
Ludger Klimek, Marek Jutel, Cezmi Akdis, et al.
September 24, 2020
Development and validation of Nasal Polyposis Quality of Life Questionnaire (NPQ)
Ilaria Baiardini, Giovanni Paoletti, Alessia Mariani, et al.
June 28, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact...
Enrico Heffler, Caterina Detoraki, Marco Contoli, et al.
June 26, 2020
Care about patients with chronic rhinosinusitis and type-2 inflammation       
Francesca Pirola, Enrico Heffler, Giovanni Paoletti, et al.
June 24, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact...
Enrico Heffler, Caterina Detoraki, Marco Contoli, et al.